These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14597742)

  • 41. Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival.
    Sze DY; Freeman SM; Slonim SM; Samuels SL; Andrews JC; Hicks M; Ahrar K; Gupta S; Reid TR
    J Vasc Interv Radiol; 2003 Mar; 14(3):279-90. PubMed ID: 12631632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
    Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO
    Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
    Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
    Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.
    Edwards SJ; Dix BR; Myers CJ; Dobson-Le D; Huschtscha L; Hibma M; Royds J; Braithwaite AW
    J Virol; 2002 Dec; 76(24):12483-90. PubMed ID: 12438574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
    Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
    J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.
    Mulvihill S; Warren R; Venook A; Adler A; Randlev B; Heise C; Kirn D
    Gene Ther; 2001 Feb; 8(4):308-15. PubMed ID: 11313805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
    Nankivell P; Williams H; Webster K; Pearson D; High A; MacLennan K; Senguven B; McConkey C; Rabbitts P; Mehanna H
    J Oral Pathol Med; 2014 Apr; 43(4):245-9. PubMed ID: 24372672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
    Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
    Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HPV and p53 expression in dysplastic lesions and squamous carcinomas of the oral mucosa.
    Simionescu C; Mărgăritescu C; Georgescu CV; Surpăţeanu M
    Rom J Morphol Embryol; 2005; 46(2):155-9. PubMed ID: 16287003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dark epithelial cells in oral premalignant lesions].
    Lai DR; Lin LM; Chen HR
    Zhonghua Ya Yi Xue Hui Za Zhi; 1990 Mar; 9(1):20-5. PubMed ID: 2131159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
    Kerdpon D; Rich AM; Reade PC
    Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
    Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
    Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
    Geoerger B; Grill J; Opolon P; Morizet J; Aubert G; Terrier-Lacombe MJ; Bressac De-Paillerets B; Barrois M; Feunteun J; Kirn DH; Vassal G
    Cancer Res; 2002 Feb; 62(3):764-72. PubMed ID: 11830531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ONYX-015. Onyx Pharmaceuticals.
    Cohen EE; Rudin CM
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1770-5. PubMed ID: 11892945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct immunofluorescence testing results in cases of premalignant and malignant oral lesions.
    Montague LJ; Bhattacharyya I; Islam MN; Cohen DM; Fitzpatrick SG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jun; 119(6):675-83. PubMed ID: 25840514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.
    Hann B; Balmain A
    J Virol; 2003 Nov; 77(21):11588-95. PubMed ID: 14557644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Precancerous lesions of the buccal mucosa].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators.
    Ralhan R; Chakravarti N; Kaur J; Sharma C; Kumar A; Mathur M; Bahadur S; Shukla NK; Deo SV
    Int J Cancer; 2006 Mar; 118(5):1077-89. PubMed ID: 16161051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.